Roberto Bianco
Impact in
- Oncology top 0.5%
- HER2/EGFR in Cancer Research
- Colorectal Cancer Treatments and Studies
- Lung Cancer Research Studies
- Cancer Treatment and Pharmacology
- Pulmonary and Respiratory Medicine top 0.5%
- Lung Cancer Treatments and Mutations
Papers in
- Oncology 87
- HER2/EGFR in Cancer Research 34
- Colorectal Cancer Treatments and Studies 16
- Cancer Immunotherapy and Biomarkers 10
- Pancreatic and Hepatic Oncology Research 10
- Cancer Treatment and Pharmacology 9
-
- Lung Cancer Treatments and Mutations 31
- Co-authors
- Fortunato Ciardiello (56 shared papers)Giampaolo Tortora (56 shared papers)Sabino De Placido (47 shared papers)Vincenzo Damiano (25 shared papers)Rosa Caputo (13 shared papers)A R Bianco (18 shared papers)G Pomatico (6 shared papers)Gabriella Fontanini (11 shared papers)
- Journals
- Clinical Cancer Research (16 papers)British Journal of Cancer (9 papers)Insights into Imaging (8 papers)Cancers (8 papers)Oncotarget (7 papers)
- Partner nations
- ItalyUnited StatesBrazil
In The Last Decade
Roberto Bianco
219 papers receiving 9.8k citations
Roberto Bianco's Hit Papers
Peers
Comparison fields: 5 of 142
- Oncology 4.5k
- Pulmonary and Respiratory Medicine 3.1k
- Cancer Research 1.2k
- Molecular Biology 3.5k
- Radiology, Nuclear Medicine and Imaging 816
Countries citing papers authored by Roberto Bianco
This map shows the geographic impact of Roberto Bianco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberto Bianco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberto Bianco more than expected).
Fields of papers citing papers by Roberto Bianco
This network shows the impact of papers produced by Roberto Bianco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberto Bianco. The network helps show where Roberto Bianco may publish in the future.
Co-authors
The 25 scholars most cited alongside Roberto Bianco, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 234 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Antitumor effect and potentiation of cytotoxic drugs activity in human cancer cells by ZD-1839 (Iressa), an epidermal growth factor receptor-selective tyrosine kinase inhibitor. Hit paper breakdown → | 2000 | 860 |
| 2 | Inhibition of growth factor production and angiogenesis in human cancer cells by ZD1839 (Iressa), a selective epidermal growth factor receptor tyrosine kinase inhibitor. | 2001 | 560 |
| 3 | Epidermal growth factor receptor (HER1) tyrosine kinase inhibitor ZD1839 (Iressa) inhibits HER2/neu (erbB2)-overexpressing breast cancer cells in vitro and in vivo. | 2001 | 481 |
| 4 | 2003 | 388 | |
| 5 | Antiangiogenic and antitumor activity of anti-epidermal growth factor receptor C225 monoclonal antibody in combination with vascular endothelial growth factor antisense oligonucleotide in human GEO colon cancer cells. | 2000 | 335 |
| 6 | 1999 | 318 | |
| 7 | 2004 | 309 | |
| 8 | Antitumor activity of sequential treatment with topotecan and anti-epidermal growth factor receptor monoclonal antibody C225. | 1999 | 295 |
| 9 | Enhancement of antitumor activity of ionizing radiation by combined treatment with the selective epidermal growth factor receptor-tyrosine kinase inhibitor ZD1839 (Iressa). | 2002 | 213 |
| 10 | 2003 | 176 | |
| 11 | 2005 | 160 | |
| 12 | 2017 | 155 | |
| 13 | 2019 | 145 | |
| 14 | 2013 | 138 | |
| 15 | Combination of a selective cyclooxygenase-2 inhibitor with epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 and protein kinase A antisense causes cooperative antitumor and antiangiogenic effect. | 2003 | 135 |
| 16 | 2015 | 135 | |
| 17 | Role of FGFR3 in bladder cancer: Treatment landscape and future challenges Hit paper breakdown → | 2023 | 126 |
| 18 | 2008 | 124 | |
| 19 | 2007 | 117 | |
| 20 | 2006 | 113 |
About Roberto Bianco
Roberto Bianco is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging, Cancer Research and Surgery, having authored 234 papers that have together received 10.2k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (34 papers), Lung Cancer Treatments and Mutations (31 papers), Colorectal Cancer Treatments and Studies (16 papers), Monoclonal and Polyclonal Antibodies Research (16 papers), PI3K/AKT/mTOR signaling in cancer (13 papers), Cancer Immunotherapy and Biomarkers (10 papers), Pancreatic and Hepatic Oncology Research (10 papers) and Cancer Treatment and Pharmacology (9 papers). The work is most often cited by research in Oncology (4.5k citations), Pulmonary and Respiratory Medicine (3.1k citations), Cancer Research (1.2k citations), Molecular Biology (3.5k citations) and Radiology, Nuclear Medicine and Imaging (816 citations). Roberto Bianco has collaborated with scholars based in Italy, United States and Brazil. Frequent co-authors include Fortunato Ciardiello, Giampaolo Tortora, Sabino De Placido, Vincenzo Damiano, Rosa Caputo, A R Bianco, G Pomatico, Gabriella Fontanini, Roberta Rosa and Massimo Tonolini. Their work appears in journals such as Clinical Cancer Research, British Journal of Cancer, Insights into Imaging, Cancers and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.